符合检索条件的记录共3条
共 1 页 当前第 1 页　　返回检索页

1	药品名称	WYDASE
	申请号	006343	产品号	002
	活性成分	HYALURONIDASE	市场状态	停止上市
	剂型或给药途径	INJECTABLE;INJECTION	规格	150 UNITS/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
	治疗等效代码		参比药物	否
	批准日期	Approved Prior to Jan 1, 1982	申请机构	BAXTER HEALTHCARE CORP ANESTHESIA AND CRITICAL CARE
2	药品名称	WYDASE
	申请号	006343	产品号	005
	活性成分	HYALURONIDASE	市场状态	停止上市
	剂型或给药途径	INJECTABLE;INJECTION	规格	1,500 UNITS/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
	治疗等效代码		参比药物	否
	批准日期	Approved Prior to Jan 1, 1982	申请机构	BAXTER HEALTHCARE CORP ANESTHESIA AND CRITICAL CARE
3	药品名称	WYDASE
	申请号	006343	产品号	006
	活性成分	HYALURONIDASE	市场状态	停止上市
	剂型或给药途径	INJECTABLE;INJECTION	规格	150 UNITS/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
	治疗等效代码		参比药物	否
	批准日期	Approved Prior to Jan 1, 1982	申请机构	BAXTER HEALTHCARE CORP ANESTHESIA AND CRITICAL CARE

©2006-2024 DrugFuture->U.S. FDA Drugs Database